Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth - PubMed
Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth
F Bussolino et al. J Cell Biol. 1992 Nov.
Abstract
Hepatocyte Growth Factor (HGF, also known as Scatter Factor) is a powerful mitogen or motility factor in different cells, acting through the tyrosine kinase receptor encoded by the MET protooncogene. Endothelial cells express the MET gene and expose at the cell surface the mature protein (p190MET) made of a 50 kD (alpha) subunit disulfide linked to a 145-kD (beta) subunit. HGF binding to endothelial cells identifies two sites with different affinities. The higher affinity binding site (Kd = 0.35 nM) corresponds to the p190MET receptor. Sub-nanomolar concentrations of HGF, but not of a recombinant inactive precursor, stimulate the receptor kinase activity, cell proliferation and motility. HGF induces repairs of a wound in endothelial cell monolayer. HGF stimulates the scatter of endothelial cells grown on three-dimensional collagen gels, inducing an elongated phenotype. In the rabbit cornea, highly purified HGF promotes neovascularization at sub-nanomolar concentrations. HGF lacks activities related to hemostasis-thrombosis, inflammation and endothelial cells accessory functions. These data show that HGF is an in vivo potent angiogenic factor and in vitro induces endothelial cells to proliferate and migrate.
Similar articles
-
The hepatocyte growth factor and its receptor.
Galimi F, Brizzi MF, Comoglio PM. Galimi F, et al. Stem Cells. 1993 Jul;11 Suppl 2:22-30. doi: 10.1002/stem.5530110805. Stem Cells. 1993. PMID: 8401259 Review.
-
Zlot C, Ingle G, Hongo J, Yang S, Sheng Z, Schwall R, Paoni N, Wang F, Peale FV Jr, Gerritsen ME. Zlot C, et al. J Biol Chem. 2003 Nov 28;278(48):47654-9. doi: 10.1074/jbc.M301353200. Epub 2003 Sep 17. J Biol Chem. 2003. PMID: 14500721
-
Hepatocyte growth factor/scatter factor stimulates the Ras-guanine nucleotide exchanger.
Graziani A, Gramaglia D, dalla Zonca P, Comoglio PM. Graziani A, et al. J Biol Chem. 1993 May 5;268(13):9165-8. J Biol Chem. 1993. PMID: 8387483
-
Jiang WG, Hiscox SE, Parr C, Martin TA, Matsumoto K, Nakamura T, Mansel RE. Jiang WG, et al. Clin Cancer Res. 1999 Nov;5(11):3695-703. Clin Cancer Res. 1999. PMID: 10589789
Cited by
-
Makarevich P, Tsokolaeva Z, Shevelev A, Rybalkin I, Shevchenko E, Beloglazova I, Vlasik T, Tkachuk V, Parfyonova Y. Makarevich P, et al. PLoS One. 2012;7(6):e38776. doi: 10.1371/journal.pone.0038776. Epub 2012 Jun 13. PLoS One. 2012. PMID: 22719942 Free PMC article.
-
Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression.
Locatelli A, Lofgren KA, Daniel AR, Castro NE, Lange CA. Locatelli A, et al. Horm Cancer. 2012 Apr;3(1-2):14-25. doi: 10.1007/s12672-011-0097-z. Horm Cancer. 2012. PMID: 22124844 Free PMC article. Review.
-
Chen L, Wang S, Feng Y, Zhang J, Du Y, Zhang J, Ongeval CV, Ni Y, Li Y. Chen L, et al. Cells. 2021 Feb 22;10(2):463. doi: 10.3390/cells10020463. Cells. 2021. PMID: 33671534 Free PMC article. Review.
-
Leptin-cytokine crosstalk in breast cancer.
Newman G, Gonzalez-Perez RR. Newman G, et al. Mol Cell Endocrinol. 2014 Jan 25;382(1):570-582. doi: 10.1016/j.mce.2013.03.025. Epub 2013 Apr 4. Mol Cell Endocrinol. 2014. PMID: 23562747 Free PMC article. Review.
-
Weimar IS, Weijer K, van den Berk PC, Muller EJ, Miranda N, Bakker AQ, Heemskerk MH, Hekman A, de Gast GC, Gerritsen WR. Weimar IS, et al. Br J Cancer. 1999 Sep;81(1):43-53. doi: 10.1038/sj.bjc.6690649. Br J Cancer. 1999. PMID: 10487611 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous